Protective effect of Kalpaamruthaa in combating the oxidative stress posed by aflatoxin B1-induced hepatocellular carcinoma with special reference to flavonoid structure-activity relationship

Liver International

Volumn 28, Issue 2, 2008, Pages 200-213

  Umarani, Mohanasundaram ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanadham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Aflatoxin B1; Antioxidants; Flavonoids; Glutathione metabolizing enzymes; Kalpaamruthaa; Lipid peroxidation; Oxidative stress

Indexed keywords

AFLATOXIN B1; AYURVEDIC DRUG; CATALASE; EMBLICA OFFICINALIS EXTRACT; FLAVONOID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; KALPAAMRUTHAA; LIPID PEROXIDE; MALONALDEHYDE; SEMECARPUS ANACARDIUM EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOLYSATE; HONEY; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; STRUCTURE ACTIVITY RELATION; TISSUE HOMOGENATE; TREATMENT DURATION;

AFLATOXIN B1; ANALYSIS OF VARIANCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CATALASE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; URIC ACID;

EID: 38849161464     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01615.x     Document Type: Article

References (116)

1. Marx JL. Oxygen free radicals linked to many disease conditions. Science 1985; 235: 529-31.
2. Pryor W. Oxy-radicals and related species, their formation, lifetimes and reactions. Ann Rev Physiol 1986; 48: 657-67.
3. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719-30.
4. Hayes JD, Mclellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Radical Res 1999; 31: 273-300.
5. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
6. van Dam PS, van Asbeck BS, Erkelens W, Marx JJM, Gispen WH, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995; 11: 181-92.
7. Singal PK, Deally CMR, Weinberg LL. Subcellular effects of adriamycin in the heart: A concise review. J Mol Cell Cardiol 1987; 19: 817-28.
8. Ito H, Miller SC, Billingham ME, et al. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci USA 1990; 87: 4275-9.
9. Hasnain SE, Begum R, Ramaiah KVA, et al. Host-pathogen interactions during apoptosis. J Biosci 2003; 28: 101-10.
10. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease - an overview. Methods Enzymol 1990; 186: 1-185.
11. Eaton DL,Gallagher GEP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994; 34: 135-72.
12. Hall AJ, Wild CP. Epidemiology of aflatoxin-related disease. In: Eaton DL, Groopman JD, eds. The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. New York, USA: Academic Press, 1994; 233-58.
13. Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 1998; 106: 289-95.
14. Amstad P, Levy A, Emerit I, Cerutti P. Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Carcinogenesis 1984; 5: 719-23.
15. Kodama M, Inoue F, Akao M. Enzymatic and non-enzymatic formation of free radicals from aflatoxin B1. Free Radical Res Commun 1990; 10: 137-42.
16. Shen HM, Ong CN, Shi CY. Involvement of reactive oxygen species in aflatoxin B1-induced cell injury in cultured rat hepatocytes. Toxicology 1995; 99: 115-23.
17. 1-induced 8-ydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 1995; 16: 419-22.
18. 1. Free Radical Biol Med 1996; 21: 139-46.
19. Kirthikar KR, Basu BD. Indian Medicinal Plants. Dehra Dun, India: Mrs. Bishen Singh, Mahendra Pal Singh, 1975; 667-9.
20. Vad BG. Study of complete regression in four cases of cancer. Indian Pract 1973; 26: 253-63.
21. Cassady JM, Chang CJ, Mclaughlin JL. Recent advances in the isolation of structural elucidation of antineoplastic agents of higher plants. In: Beal JL, Reeinhard E, eds. Natural Products as Medicinal Agents. Hippokrates, Verlag, 1981; 93-124.
22. Chitinis MP, Bhatia KG, Phatak MK, Kesava Rao KV. Antitumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumour models. Indian J Exp Biol 1980; 18: 6-8.
23. Premalatha B, Muthulakhsmi V, Vijayalakshmi T, Sachdanandam P. Semecarpus anacardium nut extract induced changes in enzymic antioxidants studied in aflatoxin B caused hepatocellular carcinoma bearing Wistar rats. Int J Pharmacognosy 1997; 35: 1-6.
24. Chopra RN, Naya SL, Chopr C. Glossary of Indian Medicinal Plants. New Delhi: C.S.I.R., 1956.
25. Rao TS, Kumari KK, Netaji B, Subhokta PKJP. A pilot study of svetaprada (leucorrhoea) with amalaka guggulu. J Res Ayurveda Siddha 1985; 6: 213.
26. Dhir H, Roy AK, Sharma A, Talukder G. Modificaton of clastogenicity of lead and aluminum in mouse bone marrow cells by dietary ingestion of Phyllanthus emblica fruit extract. Mut Res 1990; 241: 305-12.
27. Roy AK, Dhir H, Sharma A, Talukder G. Modification of metal induced micronuclei formation in mouse bone marrow erythrocytes by phyllanthus fruit extract and ascorbic acid. Toxicol Lett 1992; 62: 9-17.
28. Nandi P, Talukder G, Sharma A. Dietary chemoprevention of clastogenic effects of 3,4-benz [a] pyrene by Emblica oficinalis Gaetrn. Fruit extract. Br J Cancer 1997; 76: 1279-83.
29. Jeena K, Kuttan R. Antioxidant activity of Emblica officinalis. J Clin Biochem Nutr 1995; 19: 63-70.
30. Ghosal S, Tripathi VK, Chauhan S. Active constituents of Emblica officinalis: Part 1. The chemistry and antioxidative effects of two new hydrolysable tannins, Emblicanin A and B. Indian J Chem 1996; 35B: 941-8.
31. Aljadi AM, Kamaruddin MY. Evaluation of the phenolic contents and antioxidant capacities of two Malaysian floral honeys. Food Chem 2004; 85: 513-8.
32. Al-Mamary M, Al-Meeri A, Al-Habori M. Antioxidant activities and total phenolics of different types of honey. Nutr Res 2002; 22: 1041-7.
33. Gheldof N, Engeseth NJ. Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samples. J Agric Food Chem 2002; 50: 3050-5.
34. Gheldof N, Wang XH, Engeseth NH. Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem 2002; 50: 5870-7.
35. Schramm DD, Karim M, Schrader HR, Holt RR, Cardeti M, Keen CL. Honey with high levels of antioxidants can provide protection to healthy human subjects. J Agric Food Chemi 2003; 51: 1732-5.
36. The National Honey Board. 2002. Honey - health and therapeutic qualities. Available from: http://www.nhb.org/download/factsht/ compendium.pdf (12/11/2004).
37. Yao L, Jiang Y, Singanusong R, Datta N, Raymont K. Phenolic acids and abscissic acid in Australian Eucalyptus honeys and their potential for floral authentication. Food Chem 2003; 86: 169-77.
38. Ensminger AH, Esminger MKJ, et al. Food for Health: A Nutrition Encyclopedia. Clovis, CA: Pegus Press, 1986.
39. Gribel NV, Pashinskii VG. The antitumor properties of honey. Vopr Onkol 1990; 36: 704-9.
40. Gross H, Polagruto J, Zhu Q, Kim S, Schramm D, Keen C. Effect of honey consumption on plasma antioxidant status in human subjects. Paper presented at the 227th American Chemical Society Meeting, Anahein, CA, 2004.
41. Keast-Butler J. Honey for necrotic malignant breast ulcers. Lancet 1980; 11: 809.
42. Rao CV, Desai D, Kaul B, Amin S, Reddy BS. Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem Biol Interact 1992; 84: 277-90.
43. Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res 1995; 55: 2310-5.
44. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993; 53: 4182-8.
45. Wood R. The Whole Foods Encyclopedia. New York, NY: Prentice-Hall Press, 1988.
46. Formulary of Siddha Medicine, 2nd edn. India: The Indian Medical Practitioners Co-Operative Pharmacy and Stores Ltd, 1972, pp. 197.
47. Angsubhakorn S, Get-Ngern P, Miyamoto M, Bhamarapravati N. A single dose - response effect of aflatoxin B1 on rapid liver cancer induction in two strains of rats. Int J Cancer 1990; 46: 664-8.
48. Premalatha B, Sujatha V, Sachdanandam P. Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma. Pharmacol Res 1997; 36: 187-92.
49. Lowry OH, Rosenbrough WJ, Farren AI, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
50. Yagi K. Simple fluorimetric assay for lipid peroxidation in blood plasma. Biochem Med 1976; 15: 212-5.
51. Hogberg J, Larson RE, Kristofersch A, Orrhewices S. NADPH-dependent reductase solubilised from microsomes by peroxidation and its activity. Biochem Biophys Res Commun 1974; 56: 836-42.
52. Devasagayam TPA, Tarachand O. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 1987; 145: 134-8.
53. Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-74.
54. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-94.
55. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: Biochemical role as a component of glutathione peroxidase purification and assay. Science 1973; 179: 588-90.
56. Staal GEJ, Visser J, Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 1969; 185: 39-48.
57. Buettner GR. The pecking order of free radicals and antioxidants: Lipid peroxidation, a-tocopherol and ascorbate. Arch Biochem Biophys 1993; 300: 535-43.
58. Moron MS, Difieree JW, Mannerwik KB. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582: 67-78.
59. Quaife MC, Dju MY. Chemical estimation of vitamin E in tissue and a-tocopherol content of normal tissues. J Biol Chem 1948; 180: 263-72.
60. Omaye ST, Turabull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Meth Enzymol 1979; 62: 1-11.
61. Caraway T. Determination of uric acid in serum by a carbonate method. Am J Clin Pathol 1955; 25: 840-5.
62. Girotti MW. Mechanisms of lipid peroxidation. Free Radical Biol Med 1985; 1: 87-95.
63. Wiseman H. Dietary influences on membrane function: Importance in protection against oxidative damage and disease. J Nutr Biochem 1996; 7: 2-15.
64. Cook NC, Samman S. Flavonoids chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996; 7: 66-76.
65. Shen HM, Shi CY, Lee HP, Ong CN. Aflatoxin-B1-induced lipid peroxidation in rat liver. Toxicol Appl Pharmacol 1994; 127: 145-50.
66. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56.
67. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141-8.
68. Brandi ML. Flavonoids: Biochemical effects and therapeutic applications. Bone Mineral 1992; 19: S14.
69. Haenen GRMM, Jansen FP, Bast A. The antioxidant properties of five O-(/ 3-Hydroxyethyl)-rutosides of the flavonoid mixture Venoruton. Phlebology 1993; 1 (Suppl.): 10-7.
70. van Acker SA, van den Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ, Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radical Biol Med 1996; 20: 331-42.
71. Ghosal S, Tripathi VK, Chauhan S. Active constituents of Emblica officinalis: Part 1. The chemistry and antioxidative effects of two new hydrolysable tannins, Emblicanin A and B. Indian J Chem 1996; 35B: 941-8.
72. Sabatier S, Amiot MJMJ, Tacchini M, Aubert S. Identification of flavonoids in sunflower honey. J Food Sci 1992; 57: 773.
73. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141-8.
74. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993; 20: 21-9.
75. Kuehnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976; 24: 117-91.
76. Sanz MJ, Ferrandiz ML, Cejudo M, et al. Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica 1994; 24: 689-99.
77. van Acker SA, van Balen GP, van den Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 1998; 56: 935-43.
78. Mabry TJ, Markham KR, Thomas MB. The Systematic Identification of Flavonoids. Part 2. Berlin: Springer-Verlag, 1970.
79. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. In: Packer L, Glazer AN, eds. Methods in Enzymology: Oxygen Radicals in Biological Systems. New York: Academic Press Inc., 1990; 343-55.
80. Chaudhuri RK. Emblica cascading antioxidant: A novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol 2002; 15: 374-80.
81. Peskin AV, Koen YM, Zbarsky IB. Superoxide dismutase and glutathione peroxidase activities in tumours. FEBS Lett 1977; 78: 41-5.
82. Oberley LW, Buettner NR. Role of superoxide dismutase in cancer: A review. Cancer Res 1979; 39: 1141-9.
83. Bellisola G, Casaril M, Gabrielli G, Caraffi M, Corrocher R. Catalase activity in human hepatocellular carcinoma. Clin Biochem 1987; 20: 415-7.
84. Bozzi A, Mavelli I, Finazzi Agro A, et al. Enzymes defence against reactive oxygen derivatives II. Erythrocytes and tumour cells. Mol Cell Biochem 1976; 10: 11-6.
85. Kirkman HN, Gaetani GF. Catalse: A tetrameric enzyme with four tightly bound molecules of NADPH. Proc Natl Acad Sci USA 1984; 81: 4343-7.
86. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radical Biol Med 1997; 22: 359-78.
87. Ito H, Okamoto K, Kato K. Enhancement of expression of stress proteins by agents that lower the levels of glutathione in cells. Biochim Biophys Acta 1998; 1397: 223-30.
88. Liebau E, Wildenburg G, Walter RD, Henkle-Duhrsen K. A novel type of glutathione S-transferase in Onchocerca volvulus. Infect Immun 1994; 62: 4762-7.
89. Smith RD, Hilf R, Senior AE. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats. Cancer Res 1977; 37: 4070-4.
90. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992; 27: 337-84.
91. Sumathi R, Baskaran G, Varalakshmi P. Relationship between glutathione and DL alpha-lipoic acid against cadmium-induced hepatotoxicity. Jpn J Med Sci Biol 1996; 49: 39-48.
92. Alvarez R, Sette C, Yang D, et al. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol 1995; 48: 616-22.
93. Gaetani GF, Galiano S, Canepa L, Ferraris AM, Kirkman HN. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989; 73: 334-9.
94. Yu MW, Zhang YJ, Blaner WS, Santella RM. Influence of vitamins A, C, and E and beta-carotene on aflatoxin B1 binding to DNA in woodchuck hepatocytes. Cancer 1994; 73: 596-604.
95. Chasseaud LF. The role of glutathione and glutathione S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979; 29: 175-274.
96. Bray TM, Taylor CG. Tissue glutathione, nutrition and oxidative stress. Can J Physiol Pharmacol 1993; 71: 746-51.
97. Fiala ES, Kettering WG, Fiala S. Accumulation of hepatic mitochondria in 2-methyl-4-dimethyl-aminoazobenzene fed rats as a result of decreased degradation. Naturwissenschaften 1973; 60: 394-5.
98. Wirth PJ, Thorgeirsson SS. Glutathione synthesis and degradation in fetal and adult rat liver and Novikoff hepatoma. Cancer Res 1978; 38: 2861-5.
99. Sanz MJ, Ferrandiz ML, Cejudo M, et al. Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica 1994; 24: 689-99.
100. Sharma M, Tomasz M. Conjugation of glutathione and other thiols with bioreductively activated mitomycin C. Effect of thiols on the reductive activation rate. Chem Res Toxicol 1994; 7: 390-400.
101. McCay PB. Vitamin E: Interactions with free radicals and ascorbate. Annu Rev Nutr 1985; 5: 323-40.
102. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003; 333: 19-39.
103. Carrillo MC, Carnovale CE, Monti JA. Effect of aflatoxin B1 treatment in vivo on the in vitro activity of hepatic and extrahepatic glutathione S-transferase. Toxicol Lett 1990; 50: 107-16.
104. Nakazawa H, Genka C, Fujishima M. Pathological aspects of active oxygens/ free radicals. Jpn J Physiol 1996; 46: 15-32.
105. Wiseman H. Role of dietary phyto-oestrogens in the protection against cancer and heart disease. Biochem Soc Trans 1996; 24: 795-800.
106. Das S. Vitamin E in the genesis and prevention of cancer. A review. Acta Oncol 1994; 33: 615-9.
107. Daoud AH, Griffin AC. Effect of retinoic acid, butylated hydroxytoluene, propylgallate and selenium on 2-acetylaminofluorene induced hepatotoxicity. Cancer Lett 1985; 29: 183-8.
108. Fraga CG, Arias RF, Llesuy SF, Koch OR, Boveris A. Effect of vitamin E- and selenium-deficiency on rat liver chemiluminescence. Biochem J 1987; 242: 383-6.
109. Cameron I, Grubbs B, Rogers W. High-dose methylprednisolone, vitamin A, and vitamin C in rats bearing the rapidly growing Morris 7777 hepatoma. Cancer Treat Rep 1979; 63: 477-83.
110. Buettner GR. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993; 300: 535-43.
111. Beyer RE. The role of ascorbate in antioxidant protection of biomembranes: Interaction with vitamin E and coenzyme Q. J Bioenerg Biomembr 1994; 26: 349-58.
112. Mirvish SS. Blocking the formation of N-nitroso compounds with ascorbic acid in vitro and in vivo. Ann NY Acad Sci 1975; 258: 175-80.
113. Gebhart E, Wagner H, Gziwok K, Behnsen H. The action of anticlastogens in human lymphocytes cultures and their modification by rat-liver S9 mix II. Studies with vitamin C and E. Mutat Res 1985; 49: 84-94.
114. Giri AK, Banergee TS. Antagonistic activity of herbal drug (pyllanthus emblica) on cytological effects of environmental chemicals on mammalian cells. Cytologia 1986; 51: 375-80.
115. Dixit R, Teel RW, Daniel FB, Stoner GD. Inhibition of BaP and BaP-transdihydrodiol metabolism and DNA binding in mouse lung explants by ellagic acid. Cancer Res 1985; 45: 2951-6.
116. van Acker SA, de Groot MJ, van den Berg DJ, Tromp MN, Donné-Op den Kelder G, van der Vijgh WJ, Bast A. A quantum chemical explanation of the antioxidant activity of flavonoids. Chem Res Toxicol 1996; 9: 1305-12.